Author:
Arora Ritu,Nadar Kanika,Bajpai Urmi
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Global TB report, 2022 (https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022).
2. Dadgostar, P. Antimicrobial resistance: Implications and costs. Infect. Drug Resist. 3903–3910 (2019).
3. Majumder, M. A. A. et al. Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health. Infect. Drug Resist. 4713–4738 (2020).
4. Allué-Guardia, A., Saranathan, R., Chan, J. & Torrelles, J. B. Mycobacteriophages as potential therapeutic agents against drug-resistant tuberculosis. Int. J. Mol. Sci. 22(2), 735 (2021).
5. Zulu, M., Monde, N., Nkhoma, P., Malama, S. & Munyeme, M. Nontuberculous mycobacteria in humans, animals, and water in Zambia: A systematic review. Front. Trop. Dis. 2, 9 (2021).